Ratings Borregaard ASA Deutsche Boerse AG

Equities

BO4

NO0010657505

Real-time Estimate Tradegate Other stock markets 17:22:00 03/06/2024 BST			5-day change	1st Jan Change
16.47 ^EUR	-1.73%		-3.35%	+10.44%

05-28	Nordic Stocks Decreased Tuesday; Cadeler Posted Biggest Loss	DJ
04-24	Tranche Update on Borregaard ASA (OB:BRG)'s Equity Buyback Plan announced on November 28, 2023.	CI

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

Weaknesses

The company appears highly valued given the size of its balance sheet.
The company is highly valued given the cash flows generated by its activity.
For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

Ratings chart - Surperformance

Sector: Specialty Chemicals

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
BORREGAARD ASA	+10.44%	1.83B		-
NOVONESIS A/S	+9.94%	27.6B		B+
CATHAY BIOTECH INC.	-12.17%	3.9B	-	C+
PUYANG HUICHENG ELECTRONIC MATERIAL CO., LTD.	-6.59%	683M		-
HENAN JINDAN LACTIC ACID TECHNOLOGY CO.,LTD.	-22.80%	421M	-	-
BIO-ON S.P.A.	-81.65%	216M	-	-
CHEMCON SPECIALITY CHEMICALS LIMITED	-18.61%	104M	-	-
I-TECH AB	-4.89%	58.11M		D

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes